Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.

America's least favorite CEO was arrested Thursday.

A firm hiked the price of a drug 50-fold, and now there's new generic competition.

The American Medical Association wants a ban on ads, saying they drive up prices.

The push comes even as lawmakers discuss ways to rein in drug prices.

The new type of generic drug could reduce costs of cutting-edge medicines.

More people are insured, and biotechs are doing well, too.

From Obamacare to a generic drug supply crunch, mergers are due to lots of reasons.

A recent study suggests telling patients a drug is expensive enhances the effect.

It's "not what anybody really pays if you have private health insurance."